How do you pay?

How to pay the least

Cash price

$430+ for 30 capsules

Pharmacies pay about this for Azstarys; you’d pay more.

  1. Ask your pharmacy for Azstarys’s cash price, and one or two other pharmacies too.
  2. Azstarys’s savings card works only with insurance from a job or one you bought.

No generic is sold yet.

Compare every option

Question
Brand nameAzstarys
Authorized genericserdexmethylphenidate and dexmethylphenidate
Regular genericserdexmethylphenidate and dexmethylphenidate
What you’d pay
At least$430for 30 capsules; pharmacies pay this
Not soldThere isn’t one
Not soldNone sold yet
Same as Azstarys?
The original
–
–

Brand nameThe maker’s card

AZSTARYS Copay Savings Program

Savings card from Collegium Pharmaceutical

No insuranceNeeds insuranceNo cash price listed.
Insurance $15 or less a prescription

The card takes up to $60 a prescription off your co-pay.

Sign up on azstarys.com 

Or text SAVE to 97648, or call 1-800-910-8432.

In the maker’s words

“Patients with commercial insurance covering AZSTARYS pay no more than $15 per prescription.”

From the maker’s offer on azstarys.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Azstarys itself, from the same company, sold without the brand name, and usually for less. For now Azstarys is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

No generic is sold yet. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

AZSTARYS is a central nervous system (CNS) stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in patients 6 years of age and older.

Limitations of Use

The use of AZSTARYS is not recommended in pediatric patients younger than 6 years of age because they had higher plasma exposure and a higher incidence of adverse reactions (e.g., weight loss) than patients 6 years and older at the same dosage.

Source: the FDA label for Azstarys (Commave Sub, LLC), May 11, 2026. Full label on DailyMed 

Good to know